Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for MLN1202

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug MLN1202: Sponsors, patents, clinical trial progress

MLN1202 is an investigational drug.

There have been 7 clinical trials for MLN1202. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2005.

The most common disease conditions in clinical trials are Cardiovascular Diseases, Atherosclerosis, and Multiple Sclerosis. The leading clinical trial sponsors are Takeda, Millennium Pharmaceuticals, Inc., and Southwest Oncology Group.

Recent Clinical Trials for MLN1202
Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced MelanomaMillennium Pharmaceuticals, Inc.Phase 1
Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular DiseaseTakedaPhase 2
Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With MacroalbuminuriaTakedaPhase 2

See all MLN1202 clinical trials

Clinical Trial Summary for MLN1202

Top disease conditions for MLN1202
Top clinical trial sponsors for MLN1202

See all MLN1202 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.